Document:

Exhibit 10.59

 

AMENDMENT NO. 05 TO IRIDIUM NEXT SUPPORT
SERVICES AGREEMENT

IS-10-019 BETWEEN IRIDIUM SATELLITE LLC
AND THE BOEING COMPANY

 

 

This Amendment No. 05 (the “Amendment”)
is issued to the Iridium NEXT Support Services Agreement IS-10-019, dated May 28, 2010 (the “Agreement”) between Iridium
Satellite LLC, a Delaware limited liability company (“Iridium”) and The Boeing Company, a Delaware corporation (“Seller”).
This Amendment is dated and effective as of January 1, 2015 (“Effective Date”). Iridium and Seller may be individually
referred to as a “Party” and collectively referred to as “Parties”. Capitalized terms used but not defined
in this Amendment are used as they are defined in the Agreement.

 

WHEREAS, the Parties wish to revise Article
10 of the Agreement to support a hybrid operations and maintenance mode of both Block 1 and NEXT Space Segments.

 

NOW THEREFORE, the Parties hereby agree
to amend the Agreement as of the Effective Date as follows:

 

		1.	Articles 10.1, 10.3, and 10.4 are hereby modified in their entirety to read as follows:

 

 

10.1 Indemnification
of Iridium by Seller. Seller shall indemnify, defend and hold harmless Iridium, which is defined for the purposes of this Article
10.1 to include its divisions, subsidiaries, Affiliates, subcontractors, assignees of each, and their respective directors, officers,
employees and agents, from and against any and all Claims for injury to or death of any person or loss of or damage to any property
of any kind of a third party that occurs on the ground, together with all costs and expenses (including attorneys’ fees incident
thereto or incident to successfully establishing the right to indemnity), to the extent such injury, death, loss or damage arises
out of the gross negligence or willful misconduct of Seller and, in the case of injury to or death of any person or loss of or
damage to any property of any kind of a third party [***], to the extent such injury, death, loss or damage arises out of the negligence,
gross negligence or willful misconduct of Seller; provided, however, that in no event shall Seller be obligated to indemnify, defend
or hold harmless Iridium from any and all Claims for injury to or death of any person or loss of or damage to any property of any
kind of a third party that [***]. Seller’s obligations under this indemnity will survive the expiration, termination, completion
or cancellation of this Agreement with respect to any Claim arising before such time.

 

10.3Indemnification of
Seller by Iridium. Iridium shall indemnify, defend, and hold harmless Seller, which is defined for the purposes of this Article
10.3 to include its divisions, subsidiaries, and Affiliates, subcontractors, the assignees of each, and their respective directors,
officers and employees, from and against any and all Claims in excess of the insurance required under Article 10.5, or in the event
the insurance is not procured or maintained, does not respond, is not collectible, or is not recoverable for any reason (other
than the default of Seller), for: (a) injury to or death of any person, and for loss of, or damage to any property of any kind
of a third party; or (b) [***], both (a) and (b) to the extent resulting from or in any way relating to the performance of Seller
under this Agreement, [***], whether or not such injury, death, loss, damage or Claim is due to the negligence of Seller, together
with all costs and expenses (including attorneys’ fees incident thereto or incident to successfully establishing the right
to indemnity), but excluding injury, death, loss, damage or Claim caused by the gross negligence or willful misconduct of Seller
and excluding injury to or death of any person or loss of or damage to any property of any kind of a third party that occurs in
the Serviced Facilities to the extent such injury, death, loss or damage arises out of the negligence, gross negligence or willful
misconduct of Seller. Iridium’s obligations under this indemnity will survive the expiration, termination or completion or
cancellation of this Agreement with respect to any Claims arising before such time.

 

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

    	1

    	 

    

 

10.4 Risk of Loss. As
between the Parties, Iridium or its Affiliates shall retain all risk of loss, and loss of use, of NEXT or Block 1, or any individual
NEXT or Block 1 satellite, except in the event of Seller’s gross negligence or willful misconduct in which event Seller’s
maximum liability to Iridium (including its Affiliates, subcontractors, agents and representatives) is limited to no more than
four hundred million United States dollars (US$400,000,000) in the aggregate (the “NEXT Cap”); provided, however, that
solely with respect to any liability for risk of loss or loss of use of Block 1 or any individual Block 1 satellites, such liability
is limited, at the time of any payment with respect to Block 1 or any Block 1 satellites, to no more than the “Block 1 Cap”
(as defined below) less the aggregate amount previously paid by Seller under the NEXT Cap. For purposes hereof, “Block 1
Cap” means the sum of the total consideration paid by Iridium to Seller for authorized work under the Block 1 O&M Contract
and the “Original Contract” (as defined in the Block 1 O&M Contract). In the event of any payment by Seller for
loss, or loss of use, of both NEXT and Block 1, or any individual NEXT or Block 1 satellite, that cannot readily be allocated between
NEXT and Block 1, such payment shall be allocated to the NEXT Cap and the Block 1 Cap based on the proportion that NEXT satellites
in active commercial use (excluding NEXT satellites maintained on-orbit as a spare), and Block 1 satellites in active commercial
use (excluding Block 1 satellites maintained on-orbit as a spare), as the case may be, bear to the total number of NEXT and Block
1 satellites then in active commercial use (excluding NEXT and Block 1 satellites maintained on-orbit as a spare). Further, Iridium
hereby releases and relieves Seller, which is defined for the purposes of this Article 10.4 to include its divisions, subsidiaries,
and Affiliates, subcontractors, the assignees of each, and their respective directors, officers and employees, and waives any claim
of recovery, including claims by Iridium for loss of, loss of use of, or damage to NEXT or Block 1 or any individual NEXT or Block
1 satellite, whether or not such loss or damage is due to the negligence of Seller but not in the event of the gross negligence
or willful misconduct of Seller. Seller assumes the risk of loss for any direct damage to or loss of the property of Iridium or
its Affiliates other than the NEXT Space Segment or the Block 1 Space Segment or any individual NEXT or Block 1 satellite in each
case to the extent arising out of Seller’s gross negligence or willful misconduct. If Iridium insures against loss of or
damage to the NEXT or Block 1, or any individual NEXT or Block 1 satellites, Iridium shall cause the insurers to waive all rights
of subrogation against Seller to the maximum extent such waiver is available in the commercial insurance market for the class of
insurance procured. If such a waiver, consistent with prevailing insurance practices at the time, is available only at an additional
premium which is specifically attributable to obtaining a waiver of all rights of subrogation against Seller, then Seller, at its
option, may either pay the additional premium, at no cost to Iridium, or waive and release Iridium from its obligation to obtain
waiver of all rights of subrogation. If a waiver is not available at all, then the requirement will no longer apply, and the parties
shall negotiate in good faith a mutually acceptable alternative, provided that during negotiations each party shall continue to
perform its respective obligations under this Agreement. If the parties are unable to negotiate a mutually acceptable alternative,
Seller agrees to transition the Task-Ordered O & M Services under this Agreement to Iridium, including support of the transfer
of personnel, consistent with applicable law, and sale of assets, equipment, and software, if any, owned by Seller, at book value.

 

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

    	2

    	 

    

 

		2.	Article 10.5 is hereby modified in its entirety to read as follows:

 

10.5Insurance Provided
by Iridium. (a) In the event Iridium obtains in-orbit third party liability insurance relating to NEXT , such insurance shall
name Seller, its divisions, subsidiaries, Affiliates, subcontractors and their respective directors, officers, employees and agents,
as additional insureds. Iridium shall cause the insurers who provide in-orbit third party liability insurance for the NEXT Space
Segment to waive all rights of subrogation against Seller, its divisions, subsidiaries, Affiliates, subcontractors and their respective
directors, officers, employees and agents, to the maximum extent such waiver is available in the commercial insurance market for
the class of insurance procured, but to the extent a waiver is not available, this requirement shall no longer apply. Such insurance,
if any, shall also provide that the insurers shall give [***] days notice to Seller prior to the effective date of cancellation
of such insurance. Iridium shall provide Seller with a copy of such in-orbit third party liability insurance policy. Seller shall
be responsible and liable to Iridium for any increase in premium for such in-orbit third party liability insurance resulting from
Seller’s gross negligence or willful misconduct.

 

(b) Iridium shall procure and
maintain during the performance of this Agreement, solely applicable to to Block 1 satellites being operated and maintained under
this Agreement pursuant to authorized Task Orders, and at Iridium’s sole cost and expense, a satellite third party in-orbit
liability insurance policy (the “Block 1 In-Orbit Insurance Policy”) in such form as is reasonably satisfactory
to Seller. The Block 1 In-Orbit Insurance Policy shall name Seller, its contractors and subcontractors as additional insureds and
Iridium shall provide Seller with certificates of Insurance annually showing that Seller is named as an “additional insured”
under such policy. 

 

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

    	3

    	 

    

 

This Amendment supersedes all prior understandings,
commitments, and representations with respect to the subject matter hereof. This Amendment may not be amended, modified, or terminated,
other than as specifically provided herein, and none of its provisions may be waived, except by writing signed by an authorized
representative of both Parties. No provision of the Agreement or Task Order is amended or otherwise affected, except as is provided
above in this Amendment.

 

	IRIDIUM SATELLITE LLC	 	THE BOEING COMPANY	 
	 	 	 	 	 	 
	By:	/s/ Scott Smith	 	By:	/s/ Daneen Scott	 
	 	 	 	 	 	 
	Name:	Scott Smith	 	Name:	  Daneen Scott	 
	Title:	Chief Operating Officer	 	Title:	Senior Contract Administrator	 
	Date:	 12/19/2014	 	Date: 	12/19/2014	 

  

 

*** Certain confidential information contained in this document,
marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of
the Securities Exchange Act of 1934, as amended.

 

    	4Exhibit 4.1

 

NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
TO THE COMPANY TO SUCH EFFECT. 

 

	Warrant No. 1/2015A-_____	February 25, 2015

 

LABSTYLE INNOVATIONS CORP.

Series A Common
Stock Purchase Warrant

 

THIS CERTIFIES THAT,
for value received, [                                                  
] (the “Holder”), is entitled to subscribe for and purchase, at the Exercise Price (as defined below), from
LabStyle Innovations Corp., a Delaware corporation (the “Company”), shares of the Company’s common stock,
par value $0.0001 (the “Common Stock”), at any time prior to 5:00 p.m., New York time, on the November 25, 2015
(the “Warrant Exercise Term”).

 

This Warrant is issued
in accordance with, and subject to, the terms and conditions described in the Securities Purchase Agreement, dated February 25,
2015, between the initial Holder and the Company (the “Purchase Agreement”) entered into in connection with
the private placement offering of the Company (the “Offering”) described in the Purchase Agreement.

 

All capitalized terms used
but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.

 

This Warrant is subject to the following terms
and conditions:

 

1.            Shares.
The Holder has, subject to the terms set forth herein, the right to purchase up to an aggregate of [25% coverage] shares
of Common Stock (the “Warrant Shares”) at a per share exercise price of $0.24, subject to adjustment
as provided for herein (the “Exercise Price”).

 

2.            Exercise
of Warrant.

 

(a)          Exercise.
This Warrant may be exercised by the Holder at any time prior to the Warrant Exercise Term, in whole or in part, by delivering
the notice of exercise attached as Exhibit A hereto (the “Notice of Exercise”), duly executed by the
Holder to the Company at its principal office, or at such other office as the Company may designate, accompanied by payment, by
wire transfer of immediately available funds to the order of the Company to an account designated by the Company, of the amount
obtained by multiplying the number of Warrant Shares designated in the Notice of Exercise by the Exercise Price (the “Purchase
Price”). For purposes hereof, “Exercise Date” shall mean the date on which all deliveries required
to be made to the Company upon exercise of this Warrant pursuant to this Section 2(a) shall have been made. The
Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. No originals of the Notice
of Exercise shall be required to be delivered, nor shall any medallion guarantee (or any other type of guarantee or notarization)
of any Notice of Exercise shall be required.

 

    	1

    	 

    

 

(b)          Cashless
Exercise.  Notwithstanding anything contained herein to the contrary, if and only if the Registration Statement (as
defined in the Registration Rights Agreement) covering the resale of all or any portion of the Warrant Shares is not available
for the resale of such Warrant Shares (such unregistered portion of the Warrant Shares, the “Unavailable Warrant Shares”),
the Holder may, in its sole discretion, exercise this Warrant solely with respect to the Unavailable Warrant Shares (it being acknowledged,
for the avoidance of doubt, that this Warrant may only be exercisable with respect to registered Warrant Shares pursuant to Section
2(a) hereof) and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment
of the Aggregate Exercise Price for such Unavailable Warrant Shares, elect instead to receive upon such exercise the "Net
Number" of shares of Common Stock determined according to the following formula (a "Cashless Exercise"):

 

	 	X	=	Y  (A - B)	 
	 	 	 	A	 

 

	 	with:	X =	the number of Warrant Shares to be issued to the Holder
	 	 	 	 
	 	 	Y =	the number of Unavailable Warrant Shares with respect to which the Warrant is being exercised
	 	 	 	 
	 	 	A =	the fair value per share of Common Stock on the date of exercise of this Warrant
	 	 	 	 
	 	 	B =	the then-current Exercise Price of the Warrant

 

Solely for the purposes
of this paragraph, “fair value” per share of Common Stock shall mean (A) the average of the closing sales prices on
the Trading Market for the twenty (20) trading days immediately preceding the date on which the Notice of Exercise is deemed to
have been sent to the Company, or (B) if the Common Stock is not publicly traded as set forth above, as reasonably and in good
faith determined by the Board of Directors of the Company as of the date which the Notice of Exercise is deemed to have been sent
to the Company.

 

For purposes of Rule 144
promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a Cashless
Exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for such shares shall be deemed
to have commenced, on the date this Warrant was originally issued.

 

(c)          Issuance
of Certificates. As soon as practicable after the exercise of this Warrant, in whole or in part, in accordance with Section
2(a) or 2(b) hereof (and in no event later than two (2) Trading Days following the delivery of the Notice of Exercise), the Company,
at its expense, shall cause to be issued in the name of and delivered to the Holder: (i) a certificate or certificates for (or,
if applicable, by delivery through the facilities of the Depository Trust Company in electronic form of) the number of fully paid
and non-assessable Warrant Shares to which the Holder shall be entitled upon such exercise and, if applicable, (ii) a new warrant
of like tenor to purchase all of the Warrant Shares that may be purchased pursuant to the portion, if any, of this Warrant not
exercised by the Holder. The Holder shall for all purposes hereof be deemed to have become the Holder of record of such Warrant
Shares on the date on which the Notice of Exercise and payment of the Purchase Price in accordance with Section 2(a) hereof were
delivered and made, respectively, irrespective of the date of delivery of such certificate or certificates, except that if the
date of such delivery, notice and payment is a date when the stock transfer books of the Company are closed, such person shall
be deemed to have become the holder of record of such Warrant Shares at the close of business on the next succeeding date on which
the stock transfer books are open.

 

    	2

    	 

    

 

(d)          Taxes.
The issuance of the Warrant Shares upon the exercise of this Warrant, and the delivery of certificates or other instruments representing
such Warrant Shares, shall be made without charge to the Holder for any tax or other charge of whatever nature in respect of such
issuance and the Company shall bear any such taxes in respect of such issuance.

 

3.            Adjustment
of Exercise Price.

 

(a)          Adjustment
for Reclassification, Consolidation or Merger. If while this Warrant, or any portion hereof, remains outstanding and unexpired
there shall be (i) a reorganization or recapitalization (other than a combination, reclassification, exchange or subdivision of
shares otherwise provided for herein), (ii) a merger or consolidation of the Company with or into another corporation or other
entity in which the Company shall not be the surviving entity, or a reverse merger in which the Company shall be the surviving
entity but the shares of the Company’s capital stock outstanding immediately prior to the merger are converted by virtue
of the merger into other property, whether in the form of securities, cash or otherwise, or (iii) a sale or transfer of the Company’s
properties and assets as, or substantially as, an entirety to any other corporation or other entity in one transaction or a series
of related transactions, then, as a part of such reorganization, recapitalization, merger, consolidation, sale or transfer, unless
otherwise directed by the Holder, all necessary or appropriate lawful provisions shall be made so that the Holder shall thereafter
be entitled to receive upon exercise of this Warrant, during the period specified herein and upon payment of the Exercise Price
then in effect, the greatest number of shares of capital stock or other securities or property that a holder of the Warrant Shares
deliverable upon exercise of this Warrant would have been entitled to receive in such reorganization, recapitalization, merger,
consolidation, sale or transfer if this Warrant had been exercised immediately prior to such reorganization, recapitalization,
merger, consolidation, sale or transfer, all subject to further adjustment as provided in this Section 3. If the per share consideration
payable to the Holder for Warrant Shares in connection with any such transaction is in a form other than cash or marketable securities,
then the value of such consideration shall be determined in good faith by the Company’s Board of Directors. The foregoing
provisions of this paragraph shall similarly apply to successive reorganizations, recapitalizations, mergers, consolidations, sales
and transfers and to the capital stock or securities of any other corporation that are at the time receivable upon the exercise
of this Warrant. In all events, appropriate adjustment shall be made in the application of the provisions of this Warrant with
respect to the rights and interests of the Holder after the transaction, to the end that the provisions of this Warrant shall be
applicable after that event, as near as reasonably may be, in relation to any shares or other property deliverable or issuable
after such reorganization, recapitalization, merger, consolidation, sale or transfer upon exercise of this Warrant.

 

(b)          Adjustments
for Split, Subdivision or Combination of Shares. If while this Warrant, or any portion hereof, remains outstanding and unexpired
the Company shall subdivide (by any stock split, stock dividend, recapitalization, reorganization, reclassification or otherwise)
the shares of Common Stock subject to acquisition hereunder, then, upon the effective date of such subdivision, the Exercise Price
in effect immediately prior to such subdivision will be proportionately reduced and the number of shares of Common Stock subject
to acquisition upon exercise of the Warrant will be proportionately increased. If the Company at any time combines (by reverse
stock split, recapitalization, reorganization, reclassification or otherwise) the shares of Common Stock subject to acquisition
hereunder, then, upon the effective date of such combination, the Exercise Price in effect immediately prior to such combination
will be proportionately increased and the number of shares of Common Stock subject to acquisition upon exercise of the Warrant
will be proportionately decreased.

 

    	3

    	 

    

 

(c)          Notice
of Adjustments. Upon any adjustment of the Exercise Price and any increase or decrease in the number of Warrant Shares purchasable
upon the exercise of this Warrant, then, and in each such case, the Company, within 15 days thereafter, shall give written notice
thereof to the Holder at the address of such Holder as shown on the books of the Company, which notice shall state the Exercise
Price as adjusted and, if applicable, the increased or decreased number of Warrant Shares purchasable upon the exercise of this
Warrant, setting forth in reasonable detail the method of calculation of each.

 

4.            Notices.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in accordance
with Section 5.4 of the Purchase Agreement.

 

5.            Legends.
Unless the Warrant Shares are registered for resale with the Commission, each certificate evidencing the Warrant Shares issued
upon exercise of this Warrant shall be stamped or imprinted with a legend required pursuant to the Purchase Agreement.

 

6.            Removal
of Legend. Upon request of a holder of a certificate with the legends required by Section 5 hereof, the Company shall issue
to such holder a new certificate therefor free of any transfer legend, if, with such request, the Company shall have received an
opinion of counsel satisfactory to the Company in form and substance to the effect that any transfer by such holder of the Warrant
Shares evidenced by such certificate will not violate the Securities Act or any applicable state securities laws.

 

7.            Fractional
Shares. No fractional Warrant Shares will be issued in connection with any exercise hereunder. Instead, the Company shall round
up, as nearly as practicable to the nearest whole Share, the number of Warrant Shares to be issued.

 

8.            Rights
of Stockholders. Except as expressly provided herein, the Holder, as such, shall not be entitled to vote or be deemed the holder
of the Warrant Shares or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose,
nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a stockholder of the
Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof,
or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification
of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or otherwise
until this Warrant shall have been exercised and the Warrant Shares purchasable upon the exercise hereof shall have been issued,
as provided herein.

 

9.            No
Transfer. This Warrant shall be assignable and transferable, provided that no such assignment and transfer shall be valid unless
(a) the same shall be valid under and undertaken in accordance with applicable law, rule or regulation and (b) the provisions of
Section 5.7 of the Purchase Agreement shall be adhered to as a condition to such transfer or assignment.

 

10.           Miscellaneous.

 

(a)          This
Warrant and disputes arising hereunder shall be governed by and construed and enforced in accordance with the laws of the State
of Delaware applicable to agreements made and to be performed wholly within such State, without regard to its conflict of law rules.

 

    	4

    	 

    

 

(b)          The
headings in this Warrant are for purposes of reference only, and shall not limit or otherwise affect any of the terms hereof.

 

(c)          The
covenants of the respective parties contained herein shall survive the execution and delivery of this Warrant.

 

(d)          The
terms of this Warrant shall be binding upon and shall inure to the benefit of any successors or permitted assigns of the Company
and of the Holder and of the Warrant Shares issued or issuable upon the exercise hereof.

 

(e)          This
Warrant and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the
parties with regard to the subject hereof.

 

(f)           The
Company shall not, by amendment of its Certificate of Incorporation or Bylaws, or through any other means, directly or indirectly,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant and shall at all times in good faith assist
in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect
the rights of the Holder contained herein against impairment.

 

(g)            Upon
receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in
the case of any such loss, theft or destruction, upon delivery of an indemnity agreement reasonably satisfactory in form and amount
to the Company, or, in the case of any such mutilation, upon surrender and cancellation of such Warrant, the Company, at its expense,
will execute and deliver to the Holder, in lieu thereof, a new Warrant of like date and tenor.

 

(h)            This
Warrant and any provision hereof may be amended, waived or terminated only by an instrument in writing signed by the Company and
the Holder.

 

(i)            The
remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant and the
other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and
nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms
of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder
and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach
or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction
restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.

 

11.          Certain
Defined Terms.

 

(a)          "Closing
Sale Price" means, for any security as of any date, the last closing trade price for such security on an Eligible Market
that is the principal market for such security, as reported by Bloomberg, or, if the Eligible Market that is the principal market
for such security begins to operate on an extended hours basis and does not designate the closing trade price, then the last trade
price of such security prior to 4:00:00 p.m., New York Time, as reported by Bloomberg, or, if the Eligible Market for such security
is not the principal securities exchange or trading market for such security, the last trade price, respectively, of such security
on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if
the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board
for such security as reported by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average
of the ask prices of any market makers for such security as reported in the OTC Link or "pink sheets" by OTC Markets
Group Inc. (formerly Pink OTC Markets Inc.). If the Closing Sale Price cannot be calculated for a security on a particular date
on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually
determined by the Company and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market
value of such security, then such dispute shall be resolved pursuant to Section 1(c). All such determinations to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or other similar transaction during the applicable
calculation period.

 

    	5

    	 

    

 

(b)          "Eligible
Market" means the OTC Bulletin Board, OTCQX Market and/or OTCQB Market operated by OTC Markets Group, Inc., the NYSE MKT
LLC, The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ Capital Market or The New York Stock Exchange, Inc.

 

(c)          "Required
Holders" means the holders of Warrants issued pursuant to the Purchase Agreement representing at least a majority of the
shares of Common Stock underlying such Warrants then outstanding.

 

(d)          "Trading
Day" means any day on which the Common Stock is traded on an Eligible Market that is the principal market for such security;
provided that "Trading Day" shall not include any day on which the Common Stock is scheduled to trade on such
exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of
trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on
such exchange or market, then during the hour ending at 4:00:00 p.m., New York time).

 

IN WITNESS WHEREOF,
the Company has caused this Series A Warrant to be signed by its duly authorized officer.

 

	 	LABSTYLE INNOVATIONS CORP.
	 	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title:

 

    	6

    	 

    

 

Exhibit A

 

NOTICE OF EXERCISE

 

		TO:	LabStyle Innovations Corp., attention: President

 

The undersigned hereby
elects to purchase the below referenced shares (the “Warrant Shares”) of Common Stock of LabStyle Innovations Corp.
(the “Company”) pursuant to the terms of the attached Series A Warrant, and tenders herewith payment of the purchase
price of such Warrant Shares in full. Payment of the purchase price is being made by (check one):

 

____________  a
cash exercise with respect to _________________ Warrant Shares; or

____________  a
"cashless exercise" with respect to _______________ Warrant Shares

(if permitted pursuant
to Section 2(b) of the Warrant).

 

Please issue a certificate
or certificates representing said shares in the name of the undersigned or in such other name as is specified below:

 

1.   Name:
__________________________________________________

2.   Address:
________________________________________________

3.   DWAC
Instructions (if applicable): ___________________________________________

 

The undersigned hereby
represents and warrants the following:

 

(a)          It
(i) has such knowledge and experience in financial and business affairs that he/she/it is capable of evaluating the merits and
risks involved in purchasing the Warrant Shares, (ii) is able to bear the economic risks involved in purchasing the Warrant Shares,
and (iii) is an “accredited investor,” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act
of 1933, as amended;

 

(b)          In
making the decision to purchase the Warrant Shares, it has relied solely on independent investigations made by it and has had the
opportunity to ask questions of, and receive answers from, the Company concerning the Warrant Shares, the financial condition,
prospective business and operations of the Company and has otherwise had an opportunity to obtain any additional information, to
the extent that the Company possess such information or could acquire it without unreasonable effort or expense;

 

(c)          Its
overall commitment to investments that are not readily marketable is not disproportionate to its net worth and income, and the
purchase of the Warrant Shares will not cause such overall commitment to become disproportionate; it can afford to bear the loss
of the purchase price of the Warrant Shares;

 

(d)          It
has no present need for liquidity in its investment in the Warrant Shares; and

 

(e)          It
acknowledges that the transaction contemplated in connection with the purchase of the Warrant Shares has not been reviewed or approved
by the Securities and Exchange Commission or by any administrative agency charged with the administration of the securities laws
of any state, and that no such agency has passed on or made any recommendation or endorsement of any of the securities contemplated
hereby.

 

	 	 
	 	(Signature and Date)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}]]